Article Details
Retrieved on: 2021-07-16 12:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer Inc (NYSE: PFE) has agreed to pay $345 million to resolve claims by consumers claiming they overpaid for EpiPens due to anti-competitive and ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here